[Churg-Strauss syndrome relapse when antileucotriene in taggered].
Beduneau
G
G
Berard
H
H
Dominique
S
S
Picard
C
C
Calvet
P
P
Nouvet
G
G
D000085:Acetates / Q000009:adverse effects*; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D015267:Churg-Strauss Syndrome / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D003521:Cyclopropanes; D006801:Humans; D020024:Leukotriene Antagonists / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011804:Quinolines / Q000009:adverse effects*; D013902:Radiography, Thoracic; D012008:Recurrence; D013440:Sulfides; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D000085:Acetates; D000305:Adrenal Cortex Hormones; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast